AmikacinHearing loss and lack of efficacy : 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1853卷 / 1期

关键词：

D O I：

10.1007/s40278-021-94894-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：28 / 28

相关论文

共 50 条

[31] NivolumabDiarrhoea and lack of efficacy: 2 case reports
Reactions Weekly, 2025, 2051 (1) : 252 - 252
[32] ImatinibMyalgia and lack of efficacy: 2 case reports
Reactions Weekly, 2023, 1952 (1) : 186 - 186
[33] DapsoneMethaemoglobinaemia and lack of efficacy: 2 case reports
Reactions Weekly, 2022, 1901 (1) : 194 - 194
[34] EverolimusStomatitis and lack of efficacy: 2 case reports
Reactions Weekly, 2022, 1934 (1) : 193 - 193
[35] NivolumabDermatitis and lack of efficacy: 2 case reports
Reactions Weekly, 2024, 2039 (1) : 441 - 441
[36] MethotrexateLeukoencephalopathies and lack of efficacy: 2 case reports
Reactions Weekly, 2025, 2040 (1) : 567 - 567
[37] AntineoplasticsHearing loss, allergic reaction and lack of efficacy: 3 case reports
Reactions Weekly, 2022, 1918 (1) : 60 - 60
[38] AntibacterialsAcquired resistance and lack of efficacy: 2 case reports
Reactions Weekly, 2022, 1923 (1) : 42 - 42
[39] VoriconazoleVarious toxicities and lack of efficacy: 2 case reports
Reactions Weekly, 2023, 1965 (1) : 478 - 478
[40] Avelumab/axitinibHypertension and lack of efficacy: 2 case reports
Reactions Weekly, 2023, 1983 (1) : 84 - 84

← 1 2 3 4 5 →